List of Tables
    Table 1. Cancer Tumor Profiling Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Cancer Tumor Profiling Market Trends
    Table 3. Cancer Tumor Profiling Market Drivers
    Table 4. Cancer Tumor Profiling Market Challenges
    Table 5. Cancer Tumor Profiling Market Restraints
    Table 6. Global Cancer Tumor Profiling Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Cancer Tumor Profiling Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Cancer Tumor Profiling Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Cancer Tumor Profiling Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Cancer Tumor Profiling Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Cancer Tumor Profiling Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Cancer Tumor Profiling Revenue Share by Player, 2017-2022
    Table 13. Global Cancer Tumor Profiling Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Cancer Tumor Profiling by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Tumor Profiling as of 2021)
    Table 15. Top Players of Cancer Tumor Profiling in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Cancer Tumor Profiling Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Cancer Tumor Profiling Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Cancer Tumor Profiling Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Cancer Tumor Profiling Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Cancer Tumor Profiling Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Cancer Tumor Profiling Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Cancer Tumor Profiling Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Cancer Tumor Profiling Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Cancer Tumor Profiling Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Cancer Tumor Profiling Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Cancer Tumor Profiling Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Cancer Tumor Profiling Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Cancer Tumor Profiling Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Qiagen N.V. Company Details
    Table 31. Qiagen N.V. Business Overview
    Table 32. Qiagen N.V. Cancer Tumor Profiling Product
    Table 33. Qiagen N.V. Revenue in Cancer Tumor Profiling Business (2017-2022) & (US$ Million)
    Table 34. Qiagen N.V. Recent Development
    Table 35. Roche Molecular Systems Inc. Company Details
    Table 36. Roche Molecular Systems Inc. Business Overview
    Table 37. Roche Molecular Systems Inc. Cancer Tumor Profiling Product
    Table 38. Roche Molecular Systems Inc. Revenue in Cancer Tumor Profiling Business (2017-2022) & (US$ Million)
    Table 39. Roche Molecular Systems Inc. Recent Development
    Table 40. Abott Molecular Company Details
    Table 41. Abott Molecular Business Overview
    Table 42. Abott Molecular Cancer Tumor Profiling Product
    Table 43. Abott Molecular Revenue in Cancer Tumor Profiling Business (2017-2022) & (US$ Million)
    Table 44. Abott Molecular Recent Development
    Table 45. Illumina Inc. Company Details
    Table 46. Illumina Inc. Business Overview
    Table 47. Illumina Inc. Cancer Tumor Profiling Product
    Table 48. Illumina Inc. Revenue in Cancer Tumor Profiling Business (2017-2022) & (US$ Million)
    Table 49. Illumina Inc. Recent Development
    Table 50. NeoGenomics Laboratories Company Details
    Table 51. NeoGenomics Laboratories Business Overview
    Table 52. NeoGenomics Laboratories Cancer Tumor Profiling Product
    Table 53. NeoGenomics Laboratories Revenue in Cancer Tumor Profiling Business (2017-2022) & (US$ Million)
    Table 54. NeoGenomics Laboratories Recent Development
    Table 55. HTG Molecular Diagnostic Company Details
    Table 56. HTG Molecular Diagnostic Business Overview
    Table 57. HTG Molecular Diagnostic Cancer Tumor Profiling Product
    Table 58. HTG Molecular Diagnostic Revenue in Cancer Tumor Profiling Business (2017-2022) & (US$ Million)
    Table 59. HTG Molecular Diagnostic Recent Development
    Table 60. Genomic Health Inc. Company Details
    Table 61. Genomic Health Inc. Business Overview
    Table 62. Genomic Health Inc. Cancer Tumor Profiling Product
    Table 63. Genomic Health Inc. Revenue in Cancer Tumor Profiling Business (2017-2022) & (US$ Million)
    Table 64. Genomic Health Inc. Recent Development
    Table 65. Hologic Gen-Probe Company Details
    Table 66. Hologic Gen-Probe Business Overview
    Table 67. Hologic Gen-Probe Cancer Tumor Profiling Product
    Table 68. Hologic Gen-Probe Revenue in Cancer Tumor Profiling Business (2017-2022) & (US$ Million)
    Table 69. Hologic Gen-Probe Recent Development
    Table 70. BD Biosciences Company Details
    Table 71. BD Biosciences Business Overview
    Table 72. BD Biosciences Cancer Tumor Profiling Product
    Table 73. BD Biosciences Revenue in Cancer Tumor Profiling Business (2017-2022) & (US$ Million)
    Table 74. BD Biosciences Recent Development
    Table 75. Siemens Healthineers Company Details
    Table 76. Siemens Healthineers Business Overview
    Table 77. Siemens Healthineers Cancer Tumor Profiling Product
    Table 78. Siemens Healthineers Revenue in Cancer Tumor Profiling Business (2017-2022) & (US$ Million)
    Table 79. Siemens Healthineers Recent Development
    Table 80. Claris Life Sciences Company Details
    Table 81. Claris Life Sciences Business Overview
    Table 82. Claris Life Sciences Cancer Tumor Profiling Product
    Table 83. Claris Life Sciences Revenue in Cancer Tumor Profiling Business (2017-2022) & (US$ Million)
    Table 84. Claris Life Sciences Recent Development
    Table 85. Personal Genome Diagnostics, Inc. Company Details
    Table 86. Personal Genome Diagnostics, Inc. Business Overview
    Table 87. Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Product
    Table 88. Personal Genome Diagnostics, Inc. Revenue in Cancer Tumor Profiling Business (2017-2022) & (US$ Million)
    Table 89. Personal Genome Diagnostics, Inc. Recent Development
    Table 90. Perthera, Inc. Company Details
    Table 91. Perthera, Inc. Business Overview
    Table 92. Perthera, Inc. Cancer Tumor Profiling Product
    Table 93. Perthera, Inc. Revenue in Cancer Tumor Profiling Business (2017-2022) & (US$ Million)
    Table 94. Perthera, Inc. Recent Development
    Table 95. Foundation Medicine, Inc Company Details
    Table 96. Foundation Medicine, Inc Business Overview
    Table 97. Foundation Medicine, Inc Cancer Tumor Profiling Product
    Table 98. Foundation Medicine, Inc Revenue in Cancer Tumor Profiling Business (2017-2022) & (US$ Million)
    Table 99. Foundation Medicine, Inc Recent Development
    Table 100. V., Strand Company Details
    Table 101. V., Strand Business Overview
    Table 102. V., Strand Cancer Tumor Profiling Product
    Table 103. V., Strand Revenue in Cancer Tumor Profiling Business (2017-2022) & (US$ Million)
    Table 104. V., Strand Recent Development
    Table 105. ApoCell Company Details
    Table 106. ApoCell Business Overview
    Table 107. ApoCell Cancer Tumor Profiling Product
    Table 108. ApoCell Revenue in Cancer Tumor Profiling Business (2017-2022) & (US$ Million)
    Table 109. ApoCell Recent Development
    Table 110. Contextual Genomics Company Details
    Table 111. Contextual Genomics Business Overview
    Table 112. Contextual Genomics Cancer Tumor Profiling Product
    Table 113. Contextual Genomics Revenue in Cancer Tumor Profiling Business (2017-2022) & (US$ Million)
    Table 114. Contextual Genomics Recent Development
    Table 115. Agendia Company Details
    Table 116. Agendia Business Overview
    Table 117. Agendia Cancer Tumor Profiling Product
    Table 118. Agendia Revenue in Cancer Tumor Profiling Business (2017-2022) & (US$ Million)
    Table 119. Agendia Recent Development
    Table 120. GenScript Company Details
    Table 121. GenScript Business Overview
    Table 122. GenScript Cancer Tumor Profiling Product
    Table 123. GenScript Revenue in Cancer Tumor Profiling Business (2017-2022) & (US$ Million)
    Table 124. GenScript Recent Development
    Table 125. Research Programs/Design for This Report
    Table 126. Key Data Information from Secondary Sources
    Table 127. Key Data Information from Primary Sources
List of Figures
    Figure 1. Cancer Tumor Profiling Product Picture
    Figure 2. Global Cancer Tumor Profiling Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Cancer Tumor Profiling Market Size 2017-2028 (US$ Million)
    Figure 4. United States Cancer Tumor Profiling Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Cancer Tumor Profiling Market Size 2017-2028 (US$ Million)
    Figure 6. United States Cancer Tumor Profiling Market Share in Global 2017-2028
    Figure 7. Cancer Tumor Profiling Report Years Considered
    Figure 8. Product Picture of Next-generation Sequencing (NGS)
    Figure 9. Product Picture of Polymerase Chain Reaction (PCR)
    Figure 10. Product Picture of Immunohistochemistry (IHC)
    Figure 11. Product Picture of In Situ Hybridization (ISH)
    Figure 12. Product Picture of Microarray
    Figure 13. Product Picture of Others
    Figure 14. Global Cancer Tumor Profiling Market Share by Type in 2022 & 2028
    Figure 15. Global Cancer Tumor Profiling Market Size by Type (2017-2028) & (US$ Million)
    Figure 16. Global Cancer Tumor Profiling Market Share by Type (2017-2028)
    Figure 17. United States Cancer Tumor Profiling Market Share by Type in 2022 & 2028
    Figure 18. United States Cancer Tumor Profiling Market Size by Type (2017-2028) & (US$ Million)
    Figure 19. United States Cancer Tumor Profiling Market Share by Type (2017-2028)
    Figure 20. Product Picture of Personalized Medicine
    Figure 21. Product Picture of Diagnostics
    Figure 22. Product Picture of Biomarker Discovery
    Figure 23. Product Picture of Prognostics
    Figure 24. Product Picture of Research Applications
    Figure 25. Global Cancer Tumor Profiling Market Share by Application in 2022 & 2028
    Figure 26. Global Cancer Tumor Profiling Market Size by Application (2017-2028) & (US$ Million)
    Figure 27. Global Cancer Tumor Profiling Market Share by Application (2017-2028)
    Figure 28. United States Cancer Tumor Profiling Market Share by Application in 2022 & 2028
    Figure 29. United States Cancer Tumor Profiling Market Size by Application (2017-2028) & (US$ Million)
    Figure 30. United States Cancer Tumor Profiling Market Share by Application (2017-2028)
    Figure 31. North America Cancer Tumor Profiling Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 32. U.S. Cancer Tumor Profiling Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Canada Cancer Tumor Profiling Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Europe Cancer Tumor Profiling Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 35. Germany Cancer Tumor Profiling Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. France Cancer Tumor Profiling Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. U.K. Cancer Tumor Profiling Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Italy Cancer Tumor Profiling Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Russia Cancer Tumor Profiling Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Asia-Pacific Cancer Tumor Profiling Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 41. China Cancer Tumor Profiling Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Japan Cancer Tumor Profiling Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. South Korea Cancer Tumor Profiling Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. India Cancer Tumor Profiling Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Australia Cancer Tumor Profiling Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Taiwan Cancer Tumor Profiling Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Indonesia Cancer Tumor Profiling Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Thailand Cancer Tumor Profiling Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Malaysia Cancer Tumor Profiling Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Philippines Cancer Tumor Profiling Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Latin America Cancer Tumor Profiling Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 52. Mexico Cancer Tumor Profiling Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Brazil Cancer Tumor Profiling Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Argentina Cancer Tumor Profiling Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Middle East & Africa Cancer Tumor Profiling Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 56. Turkey Cancer Tumor Profiling Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Saudi Arabia Cancer Tumor Profiling Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 58. U.A.E Cancer Tumor Profiling Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Qiagen N.V. Revenue Growth Rate in Cancer Tumor Profiling Business (2017-2022)
    Figure 60. Roche Molecular Systems Inc. Revenue Growth Rate in Cancer Tumor Profiling Business (2017-2022)
    Figure 61. Abott Molecular Revenue Growth Rate in Cancer Tumor Profiling Business (2017-2022)
    Figure 62. Illumina Inc. Revenue Growth Rate in Cancer Tumor Profiling Business (2017-2022)
    Figure 63. NeoGenomics Laboratories Revenue Growth Rate in Cancer Tumor Profiling Business (2017-2022)
    Figure 64. HTG Molecular Diagnostic Revenue Growth Rate in Cancer Tumor Profiling Business (2017-2022)
    Figure 65. Genomic Health Inc. Revenue Growth Rate in Cancer Tumor Profiling Business (2017-2022)
    Figure 66. Hologic Gen-Probe Revenue Growth Rate in Cancer Tumor Profiling Business (2017-2022)
    Figure 67. BD Biosciences Revenue Growth Rate in Cancer Tumor Profiling Business (2017-2022)
    Figure 68. Siemens Healthineers Revenue Growth Rate in Cancer Tumor Profiling Business (2017-2022)
    Figure 69. Claris Life Sciences Revenue Growth Rate in Cancer Tumor Profiling Business (2017-2022)
    Figure 70. Personal Genome Diagnostics, Inc. Revenue Growth Rate in Cancer Tumor Profiling Business (2017-2022)
    Figure 71. Perthera, Inc. Revenue Growth Rate in Cancer Tumor Profiling Business (2017-2022)
    Figure 72. Foundation Medicine, Inc Revenue Growth Rate in Cancer Tumor Profiling Business (2017-2022)
    Figure 73. V., Strand Revenue Growth Rate in Cancer Tumor Profiling Business (2017-2022)
    Figure 74. ApoCell Revenue Growth Rate in Cancer Tumor Profiling Business (2017-2022)
    Figure 75. Contextual Genomics Revenue Growth Rate in Cancer Tumor Profiling Business (2017-2022)
    Figure 76. Agendia Revenue Growth Rate in Cancer Tumor Profiling Business (2017-2022)
    Figure 77. GenScript Revenue Growth Rate in Cancer Tumor Profiling Business (2017-2022)
    Figure 78. Bottom-up and Top-down Approaches for This Report
    Figure 79. Data Triangulation
    Figure 80. Key Executives Interviewed